Novo Nordisk to begin 2024 share buybacks
Novo Nordisk to begin 2024 share buybacks
Published by Uma Rajagopal
Posted on February 6, 2024

Published by Uma Rajagopal
Posted on February 6, 2024

Novo Nordisk to begin 2024 share buybacks
OSLO (Reuters) – Novo Nordisk will on Tuesday begin the execution of its planned share buyback programme for 2024, the Danish maker of obesity drug Wegovy and diabetes treatment Ozempic said in a statement.
Novo on Jan. 31 said it planned to carry out a share repurchase plan of up to 20 billion Danish crowns ($2.88 billion) to reduce the company’s share capital and to meet obligations arising from share-based incentive programmes.
The company completed its previous 12-month share repurchase programme on Jan. 30.
($1 = 6.9337 Danish crowns)
(Reporting by Terje Solsvik, editing by Anna Ringstrom and Essi Lehto)
Explore more articles in the Top Stories category











